ID

34562

Beskrivning

Biomarkers of Remission in Rheumatoid Arthritis (BioRRA); ODM derived from: https://clinicaltrials.gov/show/NCT02219347

Länk

https://clinicaltrials.gov/show/NCT02219347

Nyckelord

  1. 2019-01-19 2019-01-19 -
  2. 2020-04-15 2020-04-15 -
  3. 2020-04-16 2020-04-16 - Sarah Riepenhausen
Rättsinnehavare

see on clinicaltrials.gov

Uppladdad den

19 januari 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Rheumatoid Arthritis NCT02219347

Eligibility Rheumatoid Arthritis NCT02219347

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
clinical diagnosis of rheumatoid arthritis made by consultant rheumatologist at least 12 months previously
Beskrivning

ID.1

Datatyp

boolean

current single or combination use of methotrexate, sulphasalazine and/or hydroxychloroquine
Beskrivning

ID.2

Datatyp

boolean

arthritis currently in remission, as judged clinically by referring healthcare professional
Beskrivning

ID.3

Datatyp

boolean

willing to consider dmard withdrawal
Beskrivning

ID.4

Datatyp

boolean

Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of biologic therapy within the past 6 months
Beskrivning

ID.5

Datatyp

boolean

received steroids within past 3 months (enteral, parenteral or intra-articular)
Beskrivning

ID.6

Datatyp

boolean

use of any dmard other than methotrexate, sulphasalazine or hydroxychloroquine within the past 6 months (or past 12 months for leflunomide)
Beskrivning

ID.7

Datatyp

boolean

current pregnancy, or pregnancy planned within next 6 months
Beskrivning

ID.8

Datatyp

boolean

current participation within another clinical trial
Beskrivning

ID.9

Datatyp

boolean

inability to provide informed consent
Beskrivning

ID.10

Datatyp

boolean

Similar models

Eligibility Rheumatoid Arthritis NCT02219347

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
clinical diagnosis of rheumatoid arthritis made by consultant rheumatologist at least 12 months previously
boolean
ID.2
Item
current single or combination use of methotrexate, sulphasalazine and/or hydroxychloroquine
boolean
ID.3
Item
arthritis currently in remission, as judged clinically by referring healthcare professional
boolean
ID.4
Item
willing to consider dmard withdrawal
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
use of biologic therapy within the past 6 months
boolean
ID.6
Item
received steroids within past 3 months (enteral, parenteral or intra-articular)
boolean
ID.7
Item
use of any dmard other than methotrexate, sulphasalazine or hydroxychloroquine within the past 6 months (or past 12 months for leflunomide)
boolean
ID.8
Item
current pregnancy, or pregnancy planned within next 6 months
boolean
ID.9
Item
current participation within another clinical trial
boolean
ID.10
Item
inability to provide informed consent
boolean

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial